Skip to main content
. 2020 May 18;180(7):962–970. doi: 10.1001/jamainternmed.2020.1602

Table 3. Influenza Vaccination Rates by Study Group Overall (Primary Analysis) and by Patient Subgroup at the End of the Study Period Excluding Self-reported Vaccinations.

Subgroup Patients who received an influenza vaccination, % P valuea
0 Reminders 1 Reminder 2 Reminders 3 Reminders
All patients 37.5 38.0 38.2 38.2 .006
Age group, y
0.5-17 52.2 51.6 54.0 52.7 .88
18-64 32.0 32.8 32.8 32.8 .001
≥65 53.2 53.1 53.0 53.8 .31
Sex
Female 37.6 37.8 37.8 37.8 .39
Male 37.3 38.3 38.6 38.8 .001
Insurance
Private 35.3 35.5 36.1 36.0 .02
Public 51.6 53.7 51.7 52.4 .07
Other or unknown 32.5 38.6 33.7 34.1 .15
Race
White 39.0 39.7 39.9 39.6 .004
Black 30.6 31.8 31.6 34.5 .28
Asian 45.8 45.1 45.3 45.4 .72
Other or unknown 32.5 32.8 33.0 33.2 .04
Ethnicity
Hispanic 36.4 36.2 37.0 38.3 .41
Non-Hispanic or unknown 37.6 38.2 38.3 38.2 .004
Received influenza vaccination in prior 2 y
Yes 62.6 63.2 62.8 63.2 .23
No 15.3 15.9 16.3 16.1 <.001
a

P values are for differences between the combination of intervention groups and the control group adjusting for all other variables in the table.